NCT02016729 A Phase 1b Study Evaluating AMG 232 Alone and in Combination With Trametinib in Acute Myeloid Leukemia Status COMPLETED Phase PHASE1
NCT01853306 A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT01723020 A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma Status COMPLETED Phase PHASE1
NCT01439152 Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors. Status COMPLETED Phase PHASE1
NCT01345019 Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma Status COMPLETED Phase PHASE3
NCT01231347 QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas Status COMPLETED Phase PHASE3
NCT01108952 The Impact of Chemotherapy on Memory Function and the Development of Traumatic Symptoms in Children With Cancer Status UNKNOWN Phase N/A
NCT00813384 A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00807859 Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT00770536 AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR Status COMPLETED Phase PHASE1
NCT00752570 A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma Status COMPLETED Phase PHASE2
NCT00630786 Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study Status COMPLETED Phase PHASE1/PHASE2
NCT00588289 Long Term Follow-Up of Patients on Children's Cancer Group Protocols- (CCG-LTF1) FOLLOW-UP DATA Status COMPLETED Phase N/A
NCT00547157 Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE2
NCT00446446 PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer) Status COMPLETED Phase PHASE2
NCT00413283 Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2